Dataset Viewer
Auto-converted to Parquet Duplicate
id
int64
nra_level
string
country_id
string
product_type
string
regulatory_category
string
dosage_form_class
string
therapeutic_area
string
on_national_EML
int64
applicant_type
string
manufacturer_origin
string
WHO_prequalified
int64
submission_year
int64
dossier_format
string
reliance_pathway
int64
joint_assessment
int64
GMP_inspection_done
int64
bioequivalence_study
int64
registration_fee_usd
int64
dossier_quality_score
int64
registration_days
int64
outcome
string
queries_raised
int64
renewal_required
int64
validity_years
int64
unregistered_market_share_pct
float64
patient_access_impact
string
1
ML2_standard
REG_005
generic_tablet_capsule
generic
solid_oral
oncology
0
importer_distributor
India
0
2,024
national_format
0
0
0
0
815
61
465
approved
1
1
5
48.2
delayed
2
ML2_standard
REG_004
traditional_herbal
herbal
solid_oral
dermatology
0
multinational
China
1
2,021
national_format
0
0
0
0
604
55
72
approved
3
1
5
55.4
unavailable
3
ML2_standard
REG_024
generic_tablet_capsule
generic
solid_oral
oncology
1
importer_distributor
India
0
2,020
national_format
0
0
0
0
646
44
49
query_raised
5
1
3
45.4
adequate
4
ML2_standard
REG_015
biological_vaccine
biological
parenteral
NCD_cardiovascular
1
multinational
India
0
2,023
ACTD
0
0
0
0
909
40
44
approved
3
1
5
56.7
delayed
5
ML2_standard
REG_013
generic_injection
generic
parenteral
TB
1
multinational
India
0
2,024
national_format
0
0
0
0
575
45
82
withdrawn
2
1
3
35.5
unavailable
6
ML2_standard
REG_027
generic_tablet_capsule
generic
solid_oral
paediatric
0
importer_distributor
Europe
0
2,022
CTD
0
0
0
1
514
40
562
query_raised
2
0
5
53.1
adequate
7
ML2_standard
REG_015
generic_tablet_capsule
generic
solid_oral
NCD_diabetes
0
importer_distributor
China
0
2,022
ACTD
0
1
0
0
761
35
31
query_raised
4
0
3
40.3
delayed
8
ML2_standard
REG_030
innovator_branded
innovator
solid_oral
NCD_cardiovascular
0
regional_manufacturer
other
0
2,023
CTD
0
0
1
0
505
32
359
query_raised
6
1
5
51.8
unavailable
9
ML2_standard
REG_052
generic_tablet_capsule
generic
solid_oral
ARV_HIV
0
multinational
India
0
2,024
CTD
0
0
0
0
760
52
165
approved
2
1
5
41.2
unavailable
10
ML2_standard
REG_002
generic_suspension_syrup
generic
liquid_oral
paediatric
1
multinational
other
0
2,022
ACTD
0
0
0
0
746
50
491
approved
3
0
5
35.4
unavailable
11
ML2_standard
REG_046
generic_tablet_capsule
generic
solid_oral
antimalarial
0
importer_distributor
India
0
2,023
abbreviated
0
0
0
0
777
26
1,513
query_raised
3
1
5
53.4
unavailable
12
ML2_standard
REG_018
generic_tablet_capsule
generic
solid_oral
TB
0
multinational
India
0
2,021
CTD
1
0
1
0
1,043
49
131
approved
2
1
3
70.9
delayed
13
ML2_standard
REG_052
generic_tablet_capsule
generic
solid_oral
NCD_cardiovascular
1
importer_distributor
India
0
2,020
abbreviated
1
0
0
0
686
51
261
rejected
2
0
5
47.6
delayed
14
ML2_standard
REG_014
generic_tablet_capsule
generic
solid_oral
TB
1
local_manufacturer
India
0
2,022
CTD
0
0
0
0
939
68
241
approved
5
1
3
57.8
unavailable
15
ML2_standard
REG_050
generic_injection
generic
parenteral
antibiotic
1
importer_distributor
India
0
2,021
abbreviated
0
0
0
0
556
48
1,035
approved
3
1
5
50.7
unavailable
16
ML2_standard
REG_028
generic_tablet_capsule
generic
solid_oral
NCD_diabetes
0
multinational
India
0
2,023
ACTD
0
0
0
0
856
51
186
approved
1
0
5
48.7
unavailable
17
ML2_standard
REG_010
medical_device_IVD
device
device
analgesic
0
local_manufacturer
India
0
2,024
abbreviated
0
0
0
0
319
67
992
approved
4
1
5
52.8
adequate
18
ML2_standard
REG_022
biosimilar
biosimilar
parenteral
dermatology
1
importer_distributor
India
0
2,023
national_format
1
0
1
0
630
45
328
approved
2
1
3
30.1
unavailable
19
ML2_standard
REG_053
biological_vaccine
biological
parenteral
ARV_HIV
1
importer_distributor
other
0
2,023
national_format
1
0
0
0
776
64
325
rejected
2
1
5
67.2
delayed
20
ML2_standard
REG_028
generic_injection
generic
parenteral
antimalarial
1
public_sector_agency
local_SSA
0
2,020
CTD
0
0
0
0
878
52
1,223
approved
4
1
5
69.5
adequate
21
ML2_standard
REG_053
generic_tablet_capsule
generic
solid_oral
antibiotic
1
local_manufacturer
Europe
0
2,022
ACTD
0
0
0
1
729
71
30
approved
5
1
5
50.1
delayed
22
ML2_standard
REG_052
generic_suspension_syrup
generic
liquid_oral
analgesic
0
public_sector_agency
China
0
2,024
CTD
0
0
0
1
1,060
52
74
approved
2
1
5
35
delayed
23
ML2_standard
REG_039
generic_injection
generic
parenteral
antibiotic
1
local_manufacturer
other
0
2,024
CTD
0
0
0
0
779
57
85
approved
6
1
3
64.6
unavailable
24
ML2_standard
REG_003
generic_tablet_capsule
generic
solid_oral
NCD_diabetes
1
multinational
other
1
2,021
CTD
0
0
0
1
395
38
90
approved
2
1
5
56.6
unavailable
25
ML2_standard
REG_018
generic_suspension_syrup
generic
liquid_oral
NCD_diabetes
0
importer_distributor
other
0
2,024
CTD
0
0
0
1
880
48
165
approved
1
0
5
51.9
delayed
26
ML2_standard
REG_031
generic_tablet_capsule
generic
solid_oral
antimalarial
0
importer_distributor
other
0
2,023
national_format
0
0
0
0
542
56
343
approved
7
1
3
45.8
delayed
27
ML2_standard
REG_048
generic_tablet_capsule
generic
solid_oral
dermatology
0
local_manufacturer
local_SSA
0
2,023
national_format
0
0
1
1
929
35
429
query_raised
4
1
5
45.6
adequate
28
ML2_standard
REG_052
generic_injection
generic
parenteral
analgesic
1
local_manufacturer
other
0
2,021
abbreviated
0
0
0
0
725
44
526
approved
1
1
5
70.5
adequate
29
ML2_standard
REG_042
generic_tablet_capsule
generic
solid_oral
NCD_cardiovascular
0
public_sector_agency
local_SSA
0
2,022
abbreviated
0
0
0
1
940
51
127
query_raised
5
0
3
33.8
unavailable
30
ML2_standard
REG_017
generic_suspension_syrup
generic
liquid_oral
analgesic
0
importer_distributor
India
0
2,022
CTD
0
0
0
0
759
57
495
withdrawn
5
1
5
45.8
delayed
31
ML2_standard
REG_051
generic_tablet_capsule
generic
solid_oral
NCD_diabetes
0
multinational
India
0
2,020
ACTD
0
0
1
1
786
60
636
approved
2
1
3
39.6
adequate
32
ML2_standard
REG_006
generic_tablet_capsule
generic
solid_oral
analgesic
1
local_manufacturer
local_SSA
0
2,022
CTD
0
0
0
1
867
57
30
approved
2
1
5
51.6
adequate
33
ML2_standard
REG_045
generic_tablet_capsule
generic
solid_oral
antimalarial
0
regional_manufacturer
Europe
0
2,024
CTD
0
0
0
0
585
48
755
approved
5
1
3
56.4
delayed
34
ML2_standard
REG_045
generic_tablet_capsule
generic
solid_oral
antimalarial
1
multinational
India
0
2,024
national_format
0
0
0
1
848
34
66
approved
1
1
5
58.9
adequate
35
ML2_standard
REG_031
traditional_herbal
herbal
solid_oral
mental_health
0
importer_distributor
India
1
2,023
CTD
0
0
1
0
1,038
60
30
approved
5
1
5
46.8
delayed
36
ML2_standard
REG_051
innovator_branded
innovator
solid_oral
antimalarial
0
local_manufacturer
India
0
2,022
national_format
0
0
0
0
1,145
34
1,232
rejected
6
1
5
42.5
unavailable
37
ML2_standard
REG_028
generic_tablet_capsule
generic
solid_oral
antibiotic
0
multinational
other
0
2,024
abbreviated
0
0
0
0
630
59
1,320
approved
2
1
3
54.2
delayed
38
ML2_standard
REG_002
generic_tablet_capsule
generic
solid_oral
dermatology
1
importer_distributor
other
0
2,021
CTD
0
0
0
1
558
56
2,145
approved
1
1
5
49.7
unavailable
39
ML2_standard
REG_006
locally_manufactured
local
solid_oral
dermatology
0
multinational
India
0
2,023
CTD
0
0
0
0
701
48
83
rejected
3
1
5
48.5
adequate
40
ML2_standard
REG_033
generic_tablet_capsule
generic
solid_oral
dermatology
0
multinational
India
0
2,021
ACTD
0
0
0
0
1,144
54
281
approved
5
1
5
47.7
adequate
41
ML2_standard
REG_020
WHO_prequalified_generic
WHO_PQ
solid_oral
antibiotic
1
public_sector_agency
India
1
2,023
CTD
0
1
0
0
850
58
33
approved
2
0
5
13.5
delayed
42
ML2_standard
REG_046
medical_device_IVD
device
device
antibiotic
1
multinational
India
0
2,023
national_format
0
0
0
0
559
46
30
withdrawn
1
1
3
47.2
delayed
43
ML2_standard
REG_027
medical_device_IVD
device
device
NCD_cardiovascular
1
importer_distributor
China
0
2,023
ACTD
0
0
0
0
976
52
30
approved
7
1
5
53.5
unavailable
44
ML2_standard
REG_032
traditional_herbal
herbal
solid_oral
analgesic
1
importer_distributor
India
0
2,022
CTD
1
0
0
0
981
52
77
approved
4
1
3
56.2
delayed
45
ML2_standard
REG_050
generic_tablet_capsule
generic
solid_oral
mental_health
0
importer_distributor
other
0
2,022
ACTD
0
0
0
0
916
41
792
query_raised
5
1
3
41.4
unavailable
46
ML2_standard
REG_052
biological_vaccine
biological
parenteral
dermatology
0
importer_distributor
local_SSA
0
2,023
ACTD
0
0
0
0
828
53
94
approved
3
1
5
64.5
adequate
47
ML2_standard
REG_038
generic_tablet_capsule
generic
solid_oral
oncology
1
public_sector_agency
India
0
2,022
ACTD
0
0
1
1
903
48
1,002
query_raised
2
1
5
50.1
delayed
48
ML2_standard
REG_044
locally_manufactured
local
solid_oral
maternal_reproductive
0
importer_distributor
India
0
2,024
CTD
0
0
1
0
924
34
159
rejected
5
0
3
50.8
adequate
49
ML2_standard
REG_018
generic_tablet_capsule
generic
solid_oral
antibiotic
1
multinational
India
0
2,024
CTD
0
0
0
1
296
37
273
rejected
1
1
3
50.4
delayed
50
ML2_standard
REG_030
generic_tablet_capsule
generic
solid_oral
oncology
1
regional_manufacturer
India
0
2,021
CTD
0
0
0
1
1,031
51
224
approved
5
1
3
34.9
delayed
51
ML2_standard
REG_041
innovator_branded
innovator
solid_oral
analgesic
0
multinational
India
0
2,023
CTD
0
0
0
0
617
49
206
approved
3
1
3
46.8
delayed
52
ML2_standard
REG_043
traditional_herbal
herbal
solid_oral
ARV_HIV
1
local_manufacturer
other
1
2,021
ACTD
0
0
0
0
546
32
109
approved
2
1
3
72.8
adequate
53
ML2_standard
REG_051
generic_tablet_capsule
generic
solid_oral
maternal_reproductive
0
public_sector_agency
India
0
2,021
ACTD
0
0
0
0
898
57
108
approved
4
0
5
50.9
delayed
54
ML2_standard
REG_043
generic_tablet_capsule
generic
solid_oral
maternal_reproductive
1
multinational
India
0
2,023
CTD
0
0
0
0
366
45
112
approved
4
1
3
67.4
adequate
55
ML2_standard
REG_028
generic_tablet_capsule
generic
solid_oral
paediatric
1
importer_distributor
local_SSA
0
2,024
abbreviated
0
0
1
0
710
52
298
approved
0
1
5
47.8
unavailable
56
ML2_standard
REG_009
generic_tablet_capsule
generic
solid_oral
mental_health
1
multinational
local_SSA
0
2,024
CTD
0
0
0
0
288
51
651
withdrawn
4
1
5
57.5
delayed
57
ML2_standard
REG_035
generic_injection
generic
parenteral
dermatology
1
local_manufacturer
China
0
2,024
national_format
0
0
0
1
890
30
531
approved
3
1
5
34.1
adequate
58
ML2_standard
REG_032
generic_tablet_capsule
generic
solid_oral
ARV_HIV
1
public_sector_agency
China
0
2,024
CTD
0
0
0
0
902
53
1,021
withdrawn
1
1
3
48.9
adequate
59
ML2_standard
REG_017
biological_vaccine
biological
parenteral
dermatology
1
multinational
USA
0
2,023
abbreviated
0
0
0
0
1,019
27
78
approved
2
0
5
34.9
unavailable
60
ML2_standard
REG_034
medical_device_IVD
device
device
mental_health
1
importer_distributor
China
0
2,024
abbreviated
0
0
0
0
760
26
606
approved
2
0
5
44.6
adequate
61
ML2_standard
REG_047
WHO_prequalified_generic
WHO_PQ
solid_oral
ARV_HIV
1
importer_distributor
other
1
2,024
CTD
1
0
1
0
660
56
41
approved
6
1
3
60
unavailable
62
ML2_standard
REG_046
generic_suspension_syrup
generic
liquid_oral
NCD_cardiovascular
0
multinational
India
0
2,023
ACTD
0
0
0
0
577
37
873
approved
5
1
5
64.4
delayed
63
ML2_standard
REG_034
locally_manufactured
local
solid_oral
antimalarial
1
public_sector_agency
China
1
2,024
ACTD
0
0
0
0
1,351
49
134
query_raised
5
1
5
35.7
unavailable
64
ML2_standard
REG_019
generic_tablet_capsule
generic
solid_oral
antibiotic
0
importer_distributor
other
0
2,021
abbreviated
0
0
0
0
827
51
478
approved
2
1
3
49.8
delayed
65
ML2_standard
REG_045
generic_tablet_capsule
generic
solid_oral
paediatric
1
importer_distributor
local_SSA
0
2,022
national_format
0
0
0
0
919
22
706
query_raised
1
1
3
30
adequate
66
ML2_standard
REG_030
medical_device_IVD
device
device
oncology
1
importer_distributor
other
0
2,023
abbreviated
0
0
0
0
1,087
45
1,168
approved
4
1
5
33.1
unavailable
67
ML2_standard
REG_037
traditional_herbal
herbal
solid_oral
mental_health
1
local_manufacturer
India
0
2,024
CTD
0
0
0
0
423
39
1,389
approved
3
1
3
46.1
adequate
68
ML2_standard
REG_017
innovator_branded
innovator
solid_oral
paediatric
1
regional_manufacturer
other
0
2,022
ACTD
0
0
0
0
796
30
122
approved
2
1
5
55.5
adequate
69
ML2_standard
REG_008
generic_suspension_syrup
generic
liquid_oral
NCD_cardiovascular
1
multinational
India
0
2,023
abbreviated
0
0
0
0
877
50
288
query_raised
2
1
3
63.6
adequate
70
ML2_standard
REG_011
traditional_herbal
herbal
solid_oral
oncology
0
regional_manufacturer
India
0
2,021
abbreviated
0
0
0
0
877
38
30
query_raised
5
1
5
37.8
delayed
71
ML2_standard
REG_030
generic_tablet_capsule
generic
solid_oral
oncology
0
public_sector_agency
local_SSA
0
2,024
ACTD
0
0
0
1
955
30
235
approved
4
1
5
47.6
adequate
72
ML2_standard
REG_019
WHO_prequalified_generic
WHO_PQ
solid_oral
oncology
0
public_sector_agency
other
1
2,022
ACTD
0
0
1
0
853
48
56
query_raised
5
1
5
42.7
adequate
73
ML2_standard
REG_025
generic_suspension_syrup
generic
liquid_oral
ARV_HIV
0
local_manufacturer
India
0
2,024
CTD
0
0
1
0
762
31
599
withdrawn
3
1
3
38.7
unavailable
74
ML2_standard
REG_006
generic_suspension_syrup
generic
liquid_oral
maternal_reproductive
0
local_manufacturer
China
0
2,021
abbreviated
0
0
0
1
556
49
270
approved
1
1
3
43.4
unavailable
75
ML2_standard
REG_005
generic_tablet_capsule
generic
solid_oral
antimalarial
0
importer_distributor
local_SSA
0
2,024
ACTD
0
0
0
1
471
45
480
approved
1
1
3
56.7
unavailable
76
ML2_standard
REG_048
generic_suspension_syrup
generic
liquid_oral
antimalarial
1
regional_manufacturer
local_SSA
0
2,022
ACTD
0
0
0
0
552
48
229
query_raised
2
1
3
58.4
delayed
77
ML2_standard
REG_045
generic_tablet_capsule
generic
solid_oral
paediatric
0
importer_distributor
local_SSA
0
2,023
ACTD
0
0
0
0
1,150
57
191
approved
5
1
3
49.9
delayed
78
ML2_standard
REG_020
generic_suspension_syrup
generic
liquid_oral
oncology
1
importer_distributor
India
0
2,021
ACTD
0
0
0
0
338
53
244
rejected
4
1
5
56.6
unavailable
79
ML2_standard
REG_006
generic_injection
generic
parenteral
analgesic
0
public_sector_agency
India
0
2,024
CTD
0
0
0
0
979
48
189
approved
5
1
3
58.8
unavailable
80
ML2_standard
REG_054
generic_tablet_capsule
generic
solid_oral
NCD_diabetes
0
importer_distributor
India
0
2,021
national_format
0
1
1
0
759
60
33
query_raised
2
1
5
51.6
adequate
81
ML2_standard
REG_033
generic_tablet_capsule
generic
solid_oral
mental_health
1
regional_manufacturer
local_SSA
0
2,023
abbreviated
0
0
0
1
409
56
57
query_raised
0
1
5
39.4
unavailable
82
ML2_standard
REG_029
generic_suspension_syrup
generic
liquid_oral
oncology
1
local_manufacturer
Europe
0
2,020
CTD
0
0
0
0
666
60
119
approved
2
1
5
54.4
unavailable
83
ML2_standard
REG_011
generic_tablet_capsule
generic
solid_oral
analgesic
0
importer_distributor
Europe
0
2,023
CTD
0
1
0
0
1,070
47
153
withdrawn
2
1
5
41.4
unavailable
84
ML2_standard
REG_006
biological_vaccine
biological
parenteral
ARV_HIV
1
public_sector_agency
India
0
2,024
CTD
0
0
0
0
367
38
294
approved
3
1
5
39.8
delayed
85
ML2_standard
REG_044
generic_injection
generic
parenteral
dermatology
1
public_sector_agency
China
0
2,021
national_format
1
0
0
0
991
45
30
approved
3
1
3
54.9
delayed
86
ML2_standard
REG_042
generic_tablet_capsule
generic
solid_oral
oncology
0
importer_distributor
India
0
2,022
ACTD
0
0
0
1
1,031
49
36
rejected
3
1
5
52.5
delayed
87
ML2_standard
REG_005
generic_tablet_capsule
generic
solid_oral
dermatology
1
importer_distributor
India
0
2,024
ACTD
0
1
0
1
793
40
244
withdrawn
5
1
5
52.1
delayed
88
ML2_standard
REG_050
generic_tablet_capsule
generic
solid_oral
dermatology
1
multinational
India
0
2,023
CTD
0
0
0
1
1,259
38
106
rejected
3
1
5
61.6
adequate
89
ML2_standard
REG_037
generic_tablet_capsule
generic
solid_oral
paediatric
0
public_sector_agency
Europe
0
2,024
abbreviated
0
0
0
0
758
59
30
withdrawn
1
1
3
47.4
adequate
90
ML2_standard
REG_020
generic_tablet_capsule
generic
solid_oral
TB
1
local_manufacturer
India
0
2,020
CTD
0
0
0
0
777
42
167
rejected
6
0
3
65.4
unavailable
91
ML2_standard
REG_002
generic_injection
generic
parenteral
antibiotic
1
importer_distributor
local_SSA
0
2,024
CTD
0
0
1
0
847
53
211
rejected
3
1
5
50.7
delayed
92
ML2_standard
REG_003
generic_tablet_capsule
generic
solid_oral
antibiotic
0
local_manufacturer
USA
0
2,024
national_format
0
0
0
0
1,003
51
259
approved
3
1
5
59.4
adequate
93
ML2_standard
REG_028
generic_tablet_capsule
generic
solid_oral
analgesic
0
multinational
other
0
2,021
CTD
0
0
0
1
573
63
30
withdrawn
1
0
5
43.8
delayed
94
ML2_standard
REG_037
generic_tablet_capsule
generic
solid_oral
NCD_diabetes
1
public_sector_agency
India
0
2,020
CTD
0
0
0
1
559
27
1,572
approved
3
1
3
50.4
delayed
95
ML2_standard
REG_011
generic_tablet_capsule
generic
solid_oral
ARV_HIV
0
local_manufacturer
India
0
2,024
CTD
0
0
0
0
905
55
357
query_raised
2
1
3
50.1
delayed
96
ML2_standard
REG_005
biosimilar
biosimilar
parenteral
paediatric
0
importer_distributor
local_SSA
0
2,024
CTD
0
0
0
0
866
53
389
approved
2
0
5
41
adequate
97
ML2_standard
REG_011
generic_suspension_syrup
generic
liquid_oral
dermatology
0
regional_manufacturer
India
1
2,024
CTD
1
0
0
0
962
19
36
query_raised
5
1
3
54.8
adequate
98
ML2_standard
REG_015
generic_suspension_syrup
generic
liquid_oral
ARV_HIV
1
public_sector_agency
India
1
2,022
CTD
0
0
0
1
668
24
46
query_raised
2
1
5
72.8
delayed
99
ML2_standard
REG_036
generic_tablet_capsule
generic
solid_oral
antimalarial
1
importer_distributor
India
0
2,020
abbreviated
0
0
1
1
586
14
696
query_raised
4
1
3
63.7
unavailable
100
ML2_standard
REG_007
generic_injection
generic
parenteral
maternal_reproductive
1
local_manufacturer
India
0
2,023
CTD
0
0
0
1
267
65
30
query_raised
2
1
3
50.8
unavailable
End of preview. Expand in Data Studio

Drug Registration & Market Authorization Dataset

Abstract

This dataset provides 30,000 simulated drug registration dossier observations (10,000 per scenario) across three NRA capacity levels in sub-Saharan Africa. Each record represents one registration application with 30+ variables including product type, dossier quality, registration timeline, outcome, reliance pathway usage, and patient access impact. Three scenarios: strong NRA with reliance (38-day median, 91% approval), developing NRA (191-day, 55%), minimal NRA (592-day, 18%).

This dataset is entirely simulated. It must not be used for regulatory or policy decisions.

1. Introduction

Drug registration is the gateway to legal medicine access. In SSA, registration timelines range from months (ML3+ NRAs with reliance pathways) to years (ML1 countries). Only 10-30% of WHO essential medicines are registered in the lowest-income African countries. AMRH and WHO reliance/recognition pathways aim to accelerate access while maintaining quality standards.

2. Parameterization Evidence (v2.0)

Parameter Value Used Source Year
Median registration 12-36 months SSA 12-36 mo WHO 2023
EML coverage 10-30% in LICs 10-30% Lancet Commission 2017
WHO PQ ~600 products ~600 WHO PQ Programme 2023
AMRH joint assessment 30-50% faster 30-50% AMRH/AU-NEPAD 2023
African pharma market ~$30B $30B UNCTAD 2022

3. Validation

Validation Report

4. Usage

from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/drug-registration-authorization", "developing_nra_standard")
df = dataset["train"].to_pandas()
print(df.groupby('outcome').size())

5. References

  1. WHO (2023). Global landscape of pharmaceutical regulation.
  2. AMRH/AU-NEPAD. African Medicines Regulatory Harmonization.
  3. Lancet Commission (2017). Essential Medicines.
  4. WHO Prequalification Programme.
  5. UNCTAD (2022). African pharmaceutical market.

Citation

@dataset{esa_drug_reg_2025,
  title   = {Drug Registration and Market Authorization Dataset},
  author  = {{Electric Sheep Africa}},
  year    = {2025},
  publisher = {Hugging Face},
  url     = {https://huggingface.co/datasets/electricsheepafrica/drug-registration-authorization}
}

License

CC-BY-4.0

Downloads last month
33